Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Woodcock

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
AHIP Coverage|April 24, 2009
Safe & sound. Interview by Helena Gail RubinsteinJanet Woodcock
Healthplan|October 15, 2003
Assuring the benefits of modern medicine for all AmericansJanet Woodcock
Health Affairs (Project Hope)|November 11, 2008
The human genome and translational research: how much evidence is enough?Janet Woodcock
PDA Journal of Pharmaceutical Science and Technology|May 29, 2012
Reliable drug quality: an unresolved problemJanet Woodcock
The New England Journal of Medicine|November 27, 2009
A difficult balance--pain management, drug safety, and the FDAJanet Woodcock
Biomarkers in Medicine|May 19, 2010
Interview with Janet Woodcock: progress on the FDA's critical path initiativeJanet Woodcock
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 16, 2003
Risk management: issues for outcomes researchJanet Woodcock
Health Affairs (Project Hope)|September 16, 2005
The FDA and the safety of medical productsJanet Woodcock
Nature Reviews. Drug Discovery|November 24, 2004
An audience with... Janet Woodcock discusses the role of the FDA in improving pharma productivityJanet Woodcock
Nature Reviews. Drug Discovery|November 1, 2014
Paving the critical path of drug development: the CDER perspectiveJanet Woodcock
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
AHIP Coverage|April 24, 2009
Safe & sound. Interview by Helena Gail RubinsteinJanet Woodcock
Healthplan|October 15, 2003
Assuring the benefits of modern medicine for all AmericansJanet Woodcock
Health Affairs (Project Hope)|November 11, 2008
The human genome and translational research: how much evidence is enough?Janet Woodcock
PDA Journal of Pharmaceutical Science and Technology|May 29, 2012
Reliable drug quality: an unresolved problemJanet Woodcock
The New England Journal of Medicine|November 27, 2009
A difficult balance--pain management, drug safety, and the FDAJanet Woodcock
Biomarkers in Medicine|May 19, 2010
Interview with Janet Woodcock: progress on the FDA's critical path initiativeJanet Woodcock
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 16, 2003
Risk management: issues for outcomes researchJanet Woodcock
Health Affairs (Project Hope)|September 16, 2005
The FDA and the safety of medical productsJanet Woodcock
Nature Reviews. Drug Discovery|November 24, 2004
An audience with... Janet Woodcock discusses the role of the FDA in improving pharma productivityJanet Woodcock
Nature Reviews. Drug Discovery|November 1, 2014
Paving the critical path of drug development: the CDER perspectiveJanet Woodcock
Pageof 13